Navigation Links
New Alzheimer's Treatment Protocol Produces Significant Results

MYRTLE BEACH, S.C., April 11, 2013 /PRNewswire/ -- "The Alzheimerʼs Journey" DVD series was developed by Dr. Van Horn over the past five years while he was serving as medical director of both an inpatient Alzheimerʼs unit and an outpatient clinic where he worked with hundreds of Alzheimerʼs patients and families. Unwilling to accept the conventional, often ineffective approach to Alzheimerʼs treatment, Dr. Van Horn aggressively explored new and comprehensive medication protocols that are now demonstrating significant benefits. "The Alzheimerʼs Journey," combined with his website ( and his daily Alzheimer's Disease webcasts form the foundation of his mission to share his extensive clinical expertise and empower patients and families with the battle plan to "Win the War with Alzheimerʼs Disease."

(Photo: )

"The Alzheimerʼs Journey" is not as an esoteric, philosophical discussion about Alzheimerʼs Disease. It is not about future research. "The Alzheimer's Journey" is a comprehensive, directive series about what people and families can do right now to battle Alzheimerʼs Disease. As the host of "The Alzheimerʼs Journey," Dr. Van Horn presents medical information and treatment protocols in an entertaining and understandable format with a focus on three significant areas:

  1.  For people with intact memory, extensive and compelling information is presented on how to significantly reduce oneʼs risk of Alzheimerʼs Disease.
  2.  For people with the mild to moderate memory loss of Alzheimerʼs Disease, Dr. Van Horn details the unique treatment protocol he currently prescribes to significantly slow the progression of memory loss.
  3.  For families with loved ones who have advanced Alzheimerʼs Disease and are suffering with apathy, depression, insomnia, agitation or psychosis, Dr. Van Horn offers his comprehensive eight-step treatment process to restore dignity to the patient and relationship with the family.

"Most people and many doctors perceive Alzheimerʼs Disease as an illness that attacks old people with no intervention possible," remarked Dr. Van Horn . "My mission is not only to refute that perception, but to empower families with a detailed battle plan to win the war with Alzheimerʼs Disease. Every day I see the significant benefits of brain protection and aggressive medical treatment. Most information available about Alzheimerʼs Disease focuses on the suffering of patients and families. "The Alzheimerʼs Journey" offers the solution to the suffering. I am excited about "The Alzheimerʼs Journey" because I know it will tremendously benefit millions of families."

Previews of the entire series are available for viewing online at and on Facebook at

About William A. Van Horn , MD

William A. Van Horn , MD is a Diplomat of the American Board of Neurology and Psychiatry with more than twenty-five years' experience helping patients maximize the quality of their lives by ensuring proper and effective medical treatment for illnesses of the brain. Dr. Van Horn completed medical school at the University of South Alabama and received specialty training in a biological and neurological based psychiatry program at West Virginia University. He also had the privilege of working with some of the top Alzheimerʼs specialists in the United States during his Fellowship in geriatric psychiatry at Emory University. Dr. Van Horn currently serves on the Board of Directors of the South Carolina Chapter of the Alzheimerʼs Association.

For more information, or to schedule an interview with Dr. Van Horn , please contact:

Jason Frahm  
Ph. (646) 541-4304  

This press release was issued through eReleases® Press Release Distribution. For more information, visit

SOURCE William A Van Horn, MD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Merrimack Pharmaceuticals Preclinical Research Shows MM-111 Restores Sensitivity To Chemotherapy And HER2-targeted Treatment In Gastric Cancer Model
2. One-Time, One Dose Radiation Treatment Offered For Breast Cancer Patients At MedStar Georgetown University Hospital And MedStar Washington Hospital Center
3. Merrimack Pharmaceuticals Preclinical Research Shows MM-121 Restores Sensitivity to Anti-Estrogen Therapy and Delays Onset of Treatment Resistance in ER-Positive Breast Cancer Model
4. scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
5. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
6. Hadasit Bio-Holdings Flagship Portfolio Company Enlivex Awarded Orphan Drug Status for ApoCell Treatment by the FDA
7. Rapid Increase In Sclerosant Use Will Drive Steady Expansion Of US Varicose Vein Treatment Device Market
8. NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
9. For the Treatment of Lupus, the Emerging Therapies Epratuzumab and Lupuzor Have the Potential to Offer Improvements Over IV Belimumab in Reducing Disease Activity
10. Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C
11. Surveyed U.S. Physicians Indicate That Xarelto and Apixaban Will Benefit From the Lack of Use of a Fast-Acting Injectable Anticoagulant in the Treatment and Secondary Prophylaxis of Deep Vein Thrombosis/Pulmonary Embolism
Post Your Comments:
(Date:12/1/2015)... Dec. 1, 2015 WellStar Health System has ... Texas -based Tenet Healthcare,s five metro ... approved the strategic move following the conclusion of the ... clinical care models and patient safety programs that have ... to new communities. --> ...
(Date:12/1/2015)... , Dec. 1, 2015  Eyeon Therapeutics has ... dry eye treatments based on a charged hydrophilic ... delivery CDMO.  The product has been shown to ... previously published.  Mark Mitchnick , MD, CEO ... protection to additional polymers in conjunction with a ...
(Date:12/1/2015)... 1, 2015 Pharma Tech Outlook recently conducted ... Clinical Data Management Solution Providers - 2015 .  After ... comprising CEOs, CIOs, VCs, analysts, and the Pharma Tech ... of top 10 clinical data management solution providers (check ... 14 and 36 respectively). --> ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015 ... of the company’s growing product line of food safety and seafood fraud prevention ... (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable species identification for the ...
(Date:12/1/2015)... ... December 01, 2015 , ... The workstation ... lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s first portable DICOM-calibrated ... from November 29 to December 4, 2015. , MED-TAB is expected to ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... is everything. That is why Hollister Incorporated has launched the VaPro Plus Pocket™ ... next product in the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... has been awarded a fixed price per sprint agile development contract to support ... $34 million over five years, provides software engineering, infrastructure, as well as operations ...
(Date:12/1/2015)... , ... December 01, 2015 , ... XTC Semifinals ... 10 semi-finalists to head to Las Vegas for CES 2016, the world’s largest Consumer ... of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, and ...
Breaking Medicine News(10 mins):